Related Experiment Video
Updated: Jun 28, 2026

09:04
Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Hairpin ribozyme-antisense RNA constructs can act as molecular Lassos
Anne Dallas1, Svetlana V Balatskaya, Tai-Chih Kuo
1SomaGenics, Inc, Santa Cruz, CA 95060, USA.
Nucleic Acids Research
|October 28, 2008
Summary
Researchers created RNA Lassos, novel circular antisense agents that bind target RNAs. These agents effectively block gene expression and modify RNA splicing in cellular experiments.
Area of Science:
- Molecular Biology
- RNA Therapeutics
- Biochemistry
Background:
- Antisense agents are crucial for modulating gene expression.
- Developing stable and effective RNA-binding molecules remains a challenge.
- Novel strategies are needed to target specific RNA sequences for therapeutic intervention.
Purpose of the Study:
- To introduce a new class of RNA-based molecules called RNA Lassos.
- To investigate the binding properties and stability of RNA Lassos with target RNAs.
- To evaluate the efficacy of RNA Lassos in gene expression inhibition and alternative splicing modulation.
Main Methods:
- Design and synthesis of RNA Lasso precursors utilizing hairpin ribozyme.
- Self-processing of precursors to generate circular and linear RNA Lasso forms.
- Characterization of RNA Lasso-target RNA interactions using denaturing gel electrophoresis.
- Assessing gene silencing by measuring reporter gene expression (luciferase).
- Investigating alternative splicing changes in response to RNA Lassos in cell culture.
Main Results:
- RNA Lassos were successfully synthesized and demonstrated self-processing into circular and linear forms.
- RNA Lassos formed stable noncovalent complexes with linear target RNAs and topological linkages with circular targets.
- Complexes with linear RNA targets exhibited greater stability than standard RNA duplexes.
- An anti-TNF Lasso efficiently blocked the expression of a fusion mRNA containing TNF-alpha sequence.
- Lassos targeting Fas pre-mRNA induced alterations in alternative splicing patterns in cell culture.
Conclusions:
- RNA Lassos represent a novel class of antisense agents with unique circular structures.
- These agents exhibit strong binding affinity and enhanced stability with target RNAs.
- RNA Lassos show potential for specific gene silencing and modulation of RNA splicing.
- Further development of RNA Lassos could lead to new therapeutic strategies for various diseases.
Related Concept Videos
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

